231 related articles for article (PubMed ID: 26842600)
21. Environmental enrichment reverses Aβ pathology during pregnancy in a mouse model of Alzheimer's disease.
Ziegler-Waldkirch S; Marksteiner K; Stoll J; d'Errico P; Friesen M; Eiler D; Neudel L; Sturn V; Opper I; Datta M; Prinz M; Meyer-Luehmann M
Acta Neuropathol Commun; 2018 May; 6(1):44. PubMed ID: 29855361
[TBL] [Abstract][Full Text] [Related]
22. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.
Ho L; Qin W; Pompl PN; Xiang Z; Wang J; Zhao Z; Peng Y; Cambareri G; Rocher A; Mobbs CV; Hof PR; Pasinetti GM
FASEB J; 2004 May; 18(7):902-4. PubMed ID: 15033922
[TBL] [Abstract][Full Text] [Related]
23. Evidence for altered Numb isoform levels in Alzheimer's disease patients and a triple transgenic mouse model.
Chigurupati S; Madan M; Okun E; Wei Z; Pattisapu JV; Mughal MR; Mattson MP; Chan SL
J Alzheimers Dis; 2011; 24(2):349-61. PubMed ID: 21258150
[TBL] [Abstract][Full Text] [Related]
24. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
Hwang SH; Shin EJ; Shin TJ; Lee BH; Choi SH; Kang J; Kim HJ; Kwon SH; Jang CG; Lee JH; Kim HC; Nah SY
J Alzheimers Dis; 2012; 31(1):207-23. PubMed ID: 22543851
[TBL] [Abstract][Full Text] [Related]
25. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI
J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276
[TBL] [Abstract][Full Text] [Related]
26. Amyloid-β 1-24 C-terminal truncated fragment promotes amyloid-β 1-42 aggregate formation in the healthy brain.
Mazzitelli S; Filipello F; Rasile M; Lauranzano E; Starvaggi-Cucuzza C; Tamborini M; Pozzi D; Barajon I; Giorgino T; Natalello A; Matteoli M
Acta Neuropathol Commun; 2016 Oct; 4(1):110. PubMed ID: 27724899
[TBL] [Abstract][Full Text] [Related]
27. Passive immunization against pyroglutamate-3 amyloid-β reduces plaque burden in Alzheimer-like transgenic mice: a pilot study.
Frost JL; Liu B; Kleinschmidt M; Schilling S; Demuth HU; Lemere CA
Neurodegener Dis; 2012; 10(1-4):265-70. PubMed ID: 22343072
[TBL] [Abstract][Full Text] [Related]
28. Intravenously Injected Amyloid-β Peptide With Isomerized Asp7 and Phosphorylated Ser8 Residues Inhibits Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice Model of Alzheimer's Disease.
Kozin SA; Barykin EP; Telegin GB; Chernov AS; Adzhubei AA; Radko SP; Mitkevich VA; Makarov AA
Front Neurosci; 2018; 12():518. PubMed ID: 30210271
[TBL] [Abstract][Full Text] [Related]
29. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
[TBL] [Abstract][Full Text] [Related]
30. Chemical modifications of amyloid-β(1-42) have a significant impact on the repertoire of brain amyloid-β(1-42) binding proteins.
Medvedev AE; Buneeva OA; Kopylov AT; Mitkevich VA; Kozin SA; Zgoda VG; Makarov AA
Biochimie; 2016; 128-129():55-8. PubMed ID: 27400251
[TBL] [Abstract][Full Text] [Related]
31. Conversion of Synthetic Aβ to In Vivo Active Seeds and Amyloid Plaque Formation in a Hippocampal Slice Culture Model.
Novotny R; Langer F; Mahler J; Skodras A; Vlachos A; Wegenast-Braun BM; Kaeser SA; Neher JJ; Eisele YS; Pietrowski MJ; Nilsson KP; Deller T; Staufenbiel M; Heimrich B; Jucker M
J Neurosci; 2016 May; 36(18):5084-93. PubMed ID: 27147660
[TBL] [Abstract][Full Text] [Related]
32. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
33. Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA).
Burwinkel M; Lutzenberger M; Heppner FL; Schulz-Schaeffer W; Baier M
Acta Neuropathol Commun; 2018 Mar; 6(1):23. PubMed ID: 29506560
[TBL] [Abstract][Full Text] [Related]
34. Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer's Disease Correlates with Metal Levels in the Surrounding Neuropil.
James SA; Churches QI; de Jonge MD; Birchall IE; Streltsov V; McColl G; Adlard PA; Hare DJ
ACS Chem Neurosci; 2017 Mar; 8(3):629-637. PubMed ID: 27958708
[TBL] [Abstract][Full Text] [Related]
35. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
[TBL] [Abstract][Full Text] [Related]
36. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
[TBL] [Abstract][Full Text] [Related]
37. Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.
Reid GA; Darvesh S
Neuroscience; 2015 Jul; 298():424-35. PubMed ID: 25931333
[TBL] [Abstract][Full Text] [Related]
38. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
Yang H; Yang H; Xie Z; Wang P; Bi J
Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
[TBL] [Abstract][Full Text] [Related]
39. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice.
Howell MD; Bailey LA; Cozart MA; Gannon BM; Gottschall PE
Acta Neuropathol Commun; 2015 Sep; 3():54. PubMed ID: 26337292
[TBL] [Abstract][Full Text] [Related]
40. Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition.
Langer F; Eisele YS; Fritschi SK; Staufenbiel M; Walker LC; Jucker M
J Neurosci; 2011 Oct; 31(41):14488-95. PubMed ID: 21994365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
